发明名称 | Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof | ||
摘要 | The present invention provides modulators of TNF, particularly peptides and their derivatives, particularly GEP peptides, which antagonize TNF and TNF-mediated responses, activity or signaling. The invention provides methods of antagonizing TNF and the modulation of TNF-mediated diseases or responses, including inflammatory diseases and conditions. Compositions of GEP peptides, including in combination with other inflammatory mediators, are provided. Methods of treatment, alleviation, or prevention of TNF-mediated diseases and inflammatory conditions, including rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, inflammatory bowel diseases, Chrohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, are provided. | ||
申请公布号 | US8871915(B2) | 申请公布日期 | 2014.10.28 |
申请号 | US201313739721 | 申请日期 | 2013.01.11 |
申请人 | New York University School of Medicine | 发明人 | Liu Chuanju |
分类号 | C07K14/475;A61K38/18;A61P29/00;A61K45/06;A61K49/00;G01N33/50;A61K38/00 | 主分类号 | C07K14/475 |
代理机构 | Foley & Lardner LLP | 代理人 | Foley & Lardner LLP |
主权项 | 1. An isolated peptide comprising (a) one or more granulin units of Granulin/epithelin precursor (GEP) selected from the group consisting of: granulin units F (amino acids 126-178 of SEQ ID NO: 1), A (amino acids 284-335 of SEQ ID NO: 1), and C (amino acids 366-416 of SEQ ID NO: 1); and (b) one or more linker units of GEP, wherein the peptide antagonizes TNFR1 or TNFR2 signaling, and wherein the peptide consists of a mixed portion of the full-length GEP sequence. | ||
地址 | New York NY US |